Your session is about to expire
← Back to Search
SHARE Protocol for Cognitive Impairment
Study Summary
This trial is testing whether the SHARE protocol leads to better communication and advance care planning among primary care patients with cognitive impairment and their family caregivers, compared to a control group receiving minimally enhanced usual care. SHARE includes two in-person meetings and three phone calls between the patient and caregiver and a primary care clinician.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 80 or older, speak English, can consent to treatment, have a supportive person, plan to stay in-state, and may have some memory issues.I am under 80, can make my own health decisions, and plan to stay in-state.I am over 18, speak English, help with care, attend medical visits, can hear well, don't plan to move, am not paid for my services, and passed a cognitive test.
- Group 1: Minimally Enhanced Usual Care
- Group 2: SHARE
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available slots for participants in the current clinical experiment?
"According to information available on clinicaltrials.gov, this medical experiment has resumed recruitment of participants after it was first posted in October 21st 2020 and last edited on October 11th 2022."
What is the current capacity of participants for this clinical trial?
"Affirmative. Clinicaltrials.gov details that this clinical trial is enlisting participants, beginning with its initial posting on October 21st 2020 and most recently revised on October 11th 2022. This trial needs 248 patients from 10 sites to participate in it."
How many areas in North America are conducting this medical experiment?
"Currently, 10 different medical trial sites are actively looking for patients to participate in this study. Some of the locations include Olney, Baltimore and Nottingham among other cities. To reduce travel burdens associated with participation, it is recommended that participants choose a site close to their residence."
Share this study with friends
Copy Link
Messenger